• By ICR Secretariat
  • Posted Monday, January 28, 2019

Janssen to use Apple watch for AFib

http://www.pharmatimes.com/news/janssen_to_use_apple_watch_for_afib_1275622

Johnson & Johnson’s Janssen has announced a research study using the Apple watch to help improve atrial fibrillation (AFib) outcomes, including stroke prevention, intending to to collaborate with Apple to assess the impact of the wearable technology on earlier detection of AFib, improved diagnosis and patient outcomes.